Company Profile
Smith and Nephew Stock Price, News & Catalysts
- Ticker:
- SNN
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United Kingdom and listed in the U
Stock performance
29.04 USD (-0.92%)
Close
Last updated: August 20, 2026
12.5B USD
Market cap
Why the stock is moving
As of Aug 20, 2026, SNN closed down 0.92% at $29.04. No new same-company headline was identified in the current news window.
Company overview
Business overview
Smith & Nephew is a global medical technology company focused on orthopedics, sports medicine, and advanced wound management. Its business is driven by procedure-linked demand and product innovation across surgical and restorative care.
Geographic Base and Sector Classification
Headquartered in the United Kingdom and listed in the U.S. as an ADR, Smith & Nephew has a broad international footprint. It sits in medtech rather than biotech.
Business Model Characteristics
The company earns revenue through implants, surgical systems, wound care, and related products used in hospitals and clinics. Investors watch procedure volumes, product launches, and margin trends across its core franchises.
Position Within the Biotechnology Landscape
Smith & Nephew is outside biotech but important within healthcare technology because it benefits from surgical and wound-care demand. It tends to move on clinical adoption and hospital utilization rather than drug events.
Future catalysts
- Smith & Nephew’s watchpoints are robotics adoption, sports-medicine execution, and continued recovery in orthopedics. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Smith and Nephew (SNN)?
Smith and Nephew (SNN) most recently closed at 29.04 USD, a -0.92% move versus the previous session.
What is the market cap of Smith and Nephew (SNN)?
Smith and Nephew currently has a market capitalization of 12.5B USD on BioPharmSignal.
What does Smith and Nephew do?
Smith & Nephew is a global medical technology company focused on orthopedics, sports medicine, and advanced wound management. Its business is driven by procedure-linked demand and product innovation across surgical and restorative care.
On which exchange is SNN stock listed?
Smith and Nephew (SNN) is associated with NYSE, United Kingdom and listed in the U, MedTech.
What is Smith?
Smith & Nephew’s watchpoints are robotics adoption, sports-medicine execution, and continued recovery in orthopedics.
Which conditions is Smith and Nephew targeting with Smith?
Smith & Nephew’s watchpoints are robotics adoption, sports-medicine execution, and continued recovery in orthopedics.
How does Smith and Nephew describe recent progress with Smith?
Smith & Nephew’s watchpoints are robotics adoption, sports-medicine execution, and continued recovery in orthopedics.
What is Nephew?
Smith & Nephew is a global medical technology company focused on orthopedics, sports medicine, and advanced wound management.